Melissa is a Scientific Advisor to Engage Bio. She is the co-founder of 4DMolecular Therapeutics, where she advanced multiple genetic medicines into clinical development. She also co-founded IGNITE Immunotherapy which developed oncolytic viral therapies for cancer (acquired by Pfizer). Melissa received a PhD in Chemical and Biomolecular Engineering from UC Berkeley.